Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes

Guenter J. Krejs, Richard Browne, Philip Raskin

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Somatostatin has previously been reported to reduce plasma levels of sugars and triglycerides following oral test meals. This study was designed to answer the question as to whether or not somatostatin affects transport directly by inhibiting absorption across the mucosa of the small bowel. Steady-state perfusion experiments with either glucose- and amino acid-containing test solutions or a plasmalike electrolyte solution were carried out in the jejunum of healthy subjects. During the intestinal perfusion either saline (control) or somatostatin (8 μg/ kg/h) was infused for 90 min through a peripheral vein. Somatostatin infusion significantly reduced glucose absorption, and kinetic analysis revealed that this effect was mainly due to a reduction of Vmax of glucose transport. Amino acid absorption (l-glycine and l-lysine) was also reduced by somatostatin infusion. Despite a significant decrease in undirectional water fluxes and calculated rate of water and urea diffusion, somatostatin did not affect net water or electrolyte absorption when the plasma-like electrolyte solution was perfused. These studies suggest that somatostatin inhibits glucose and amino acid absorption by a direct effect on the intestinal mucosa. Although the mechanism is unknown, we think that somatostatin most likely causes its effect by a selective reduction of functional mucosal surface area of the intestine.

Original languageEnglish (US)
Pages (from-to)26-31
Number of pages6
JournalGastroenterology
Volume78
Issue number1
StatePublished - 1980

Fingerprint

Somatostatin
Electrolytes
Amino Acids
Glucose
Water
Perfusion
Jejunum
Intestinal Mucosa
Glycine
Lysine
Intestines
Meals
Urea
Veins
Healthy Volunteers
Mucous Membrane
Triglycerides

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes. / Krejs, Guenter J.; Browne, Richard; Raskin, Philip.

In: Gastroenterology, Vol. 78, No. 1, 1980, p. 26-31.

Research output: Contribution to journalArticle

@article{2cdaaeb775d542c288abe95e576226c9,
title = "Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes",
abstract = "Somatostatin has previously been reported to reduce plasma levels of sugars and triglycerides following oral test meals. This study was designed to answer the question as to whether or not somatostatin affects transport directly by inhibiting absorption across the mucosa of the small bowel. Steady-state perfusion experiments with either glucose- and amino acid-containing test solutions or a plasmalike electrolyte solution were carried out in the jejunum of healthy subjects. During the intestinal perfusion either saline (control) or somatostatin (8 μg/ kg/h) was infused for 90 min through a peripheral vein. Somatostatin infusion significantly reduced glucose absorption, and kinetic analysis revealed that this effect was mainly due to a reduction of Vmax of glucose transport. Amino acid absorption (l-glycine and l-lysine) was also reduced by somatostatin infusion. Despite a significant decrease in undirectional water fluxes and calculated rate of water and urea diffusion, somatostatin did not affect net water or electrolyte absorption when the plasma-like electrolyte solution was perfused. These studies suggest that somatostatin inhibits glucose and amino acid absorption by a direct effect on the intestinal mucosa. Although the mechanism is unknown, we think that somatostatin most likely causes its effect by a selective reduction of functional mucosal surface area of the intestine.",
author = "Krejs, {Guenter J.} and Richard Browne and Philip Raskin",
year = "1980",
language = "English (US)",
volume = "78",
pages = "26--31",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes

AU - Krejs, Guenter J.

AU - Browne, Richard

AU - Raskin, Philip

PY - 1980

Y1 - 1980

N2 - Somatostatin has previously been reported to reduce plasma levels of sugars and triglycerides following oral test meals. This study was designed to answer the question as to whether or not somatostatin affects transport directly by inhibiting absorption across the mucosa of the small bowel. Steady-state perfusion experiments with either glucose- and amino acid-containing test solutions or a plasmalike electrolyte solution were carried out in the jejunum of healthy subjects. During the intestinal perfusion either saline (control) or somatostatin (8 μg/ kg/h) was infused for 90 min through a peripheral vein. Somatostatin infusion significantly reduced glucose absorption, and kinetic analysis revealed that this effect was mainly due to a reduction of Vmax of glucose transport. Amino acid absorption (l-glycine and l-lysine) was also reduced by somatostatin infusion. Despite a significant decrease in undirectional water fluxes and calculated rate of water and urea diffusion, somatostatin did not affect net water or electrolyte absorption when the plasma-like electrolyte solution was perfused. These studies suggest that somatostatin inhibits glucose and amino acid absorption by a direct effect on the intestinal mucosa. Although the mechanism is unknown, we think that somatostatin most likely causes its effect by a selective reduction of functional mucosal surface area of the intestine.

AB - Somatostatin has previously been reported to reduce plasma levels of sugars and triglycerides following oral test meals. This study was designed to answer the question as to whether or not somatostatin affects transport directly by inhibiting absorption across the mucosa of the small bowel. Steady-state perfusion experiments with either glucose- and amino acid-containing test solutions or a plasmalike electrolyte solution were carried out in the jejunum of healthy subjects. During the intestinal perfusion either saline (control) or somatostatin (8 μg/ kg/h) was infused for 90 min through a peripheral vein. Somatostatin infusion significantly reduced glucose absorption, and kinetic analysis revealed that this effect was mainly due to a reduction of Vmax of glucose transport. Amino acid absorption (l-glycine and l-lysine) was also reduced by somatostatin infusion. Despite a significant decrease in undirectional water fluxes and calculated rate of water and urea diffusion, somatostatin did not affect net water or electrolyte absorption when the plasma-like electrolyte solution was perfused. These studies suggest that somatostatin inhibits glucose and amino acid absorption by a direct effect on the intestinal mucosa. Although the mechanism is unknown, we think that somatostatin most likely causes its effect by a selective reduction of functional mucosal surface area of the intestine.

UR - http://www.scopus.com/inward/record.url?scp=0018915298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018915298&partnerID=8YFLogxK

M3 - Article

VL - 78

SP - 26

EP - 31

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 1

ER -